Publications

• MET alterations in advanced non-small cell lung cancer.
  Curr Probl Cancer Volume: 49 Page(s): 101075
  04/01/2024 Authors: Chagas GCL; Rangel AR; El Osta B
• A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors.
  JTO Clin Res Rep Volume: 5 Page(s): 100619
  02/01/2024 Authors: Beckermann KE; Bestvina CM; El Osta B; Sanborn RE; Borghaei H; Lammers PE; Selvaggi G; Whisenant JG; Heimann-Nichols E; Berry L
• Is It Prime Time for Perioperative Therapy in Patients With Resectable Non-Small-Cell Lung Cancer?
  JCO Oncol Pract Volume: 19 Page(s): 685 - 687
  09/01/2023 Authors: El Osta B; Ababneh O
• KRAS G12C mutation: from undruggable target to potentially agnostic biomarker.
  Transl Lung Cancer Res Volume: 12 Page(s): 1147 - 1151
  06/30/2023 Authors: El Osta B
• A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade.
  Clin Lung Cancer Volume: 23 Page(s): e400 - e404
  11/01/2022 Authors: Osta BE; Carlisle J; Steuer C; Pakkala S; Leal T; Dhodapkar M; Liu Y; Chen Z; Owonikoko T; Ramalingam S
• Novel targeted therapies for advanced non-small lung cancer.
  Semin Oncol Volume: 49 Page(s): 326 - 336
  06/01/2022 Authors: Abughanimeh O; Kaur A; El Osta B; Ganti AK
• RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC.
  JTO Clin Res Rep Volume: 1 Page(s): 100050
  09/01/2020 Authors: Osta BE; Ramalingam SS
• Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
  J Thorac Oncol Volume: 14 Page(s): 876 - 889
  05/01/2019 Authors: El Osta B; Behera M; Kim S; Berry LD; Sica G; Pillai RN; Owonikoko TK; Kris MG; Johnson BE; Kwiatkowski DJ
• First Report of Parkinsonism Associated With Indoximod, an Immune-Modulating Agent.
  J Glob Oncol Volume: 4 Page(s): 1 - 2
  09/01/2018 Authors: Floyd M; El Osta B; Tang S-C
• Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials.
  Crit Rev Oncol Hematol Volume: 119 Page(s): 1 - 12
  11/01/2017 Authors: El Osta B; Hu F; Sadek R; Chintalapally R; Tang S-C
• Acute blepharitis: an unusual complication of zoledronic acid.
  Int J Rheum Dis Volume: 20 Page(s): 515 - 518
  04/01/2017 Authors: Osta LE; Osta BE
• Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
  Cancer Discov Volume: 6 Page(s): 1352 - 1365
  12/01/2016 Authors: Hong DS; Morris VK; El Osta B; Sorokin AV; Janku F; Fu S; Overman MJ; Piha-Paul S; Subbiah V; Kee B
• Innovative Strategies for Decreasing Blood Collection Wait Times for Patients in Early-Phase Cancer Clinical Trials.
  J Oncol Pract Volume: 12 Page(s): e784 - e791
  07/01/2016 Authors: Mengistu B; Ray D; Lockett P; Dorsey V; Phipps RA; Subramanian H; Atkins JT; El Osta B; Falchook GS; Karp DD
• Immune checkpoint inhibitors (ICI): A meta-analysis of immune-related adverse events (irAE) from cancer clinical trials.
  Volume: 34
  05/20/2016 Authors: El Osta BE; Hu F; Sadek RF; Chintalapally R; Tang S-C
• Bisphosphonate-related osteonecrosis of the jaw: awareness and level of knowledge of Lebanese physicians.
  Support Care Cancer Volume: 23 Page(s): 2825 - 2831
  09/01/2015 Authors: El Osta L; El Osta B; Lakiss S; Hennequin M; El Osta N
• Phase Ib study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated metastatic colorectal cancer and advanced cancers.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 33 Page(s): 3511 - 3511
  05/20/2015 Authors: Hong DS; Morris VK; El Osta B; Fu S; Overman MJ; Piha-Paul SA; Subbiah V; Kee BK; Tsimberidou AM; Zinner R
• Phase Ib study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated metastatic colorectal cancer and advanced cancers.
  Volume: 33
  05/20/2015 Authors: Hong DS; Morris VK; El Osta BE; Fu S; Overman MJ; Piha-Paul SA; Subbiah V; Kee BK; Tsimberidou AM; Zinner R
• A survey to evaluate our physician-trainees' comfort and knowledge in communicating their final good-bye to their terminally ill patient.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 32 Page(s): 114 - 114
  11/01/2014 Authors: Marcus J; El Osta B; Sumrall B; Mott F
• New tools for enhancing the quality of phase I clinical trials: The Armada and Labtracker computer systems.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 31 Page(s): 235 - 235
  11/01/2013 Authors: Karp DD; Falchook GS; Subramanian H; Lockett P; Harleaux D; Fullmer C; El Osta B
• New tools for enhancing the quality of phase I clinical trials: The Armada and Labtracker computer systems.
  Volume: 31
  11/01/2013 Authors: Karp DD; Falchook GS; Subramanian H; Lockett P; Harleaux D; Fullmer C; El Osta BE
• Economic analysis of pharmacokinetic (PK) studies in phase I clinical trials.
  Volume: 31
  05/20/2013 Authors: El Osta BE; Falchook GS; Schaub D; Subramanian H; Daneshmand M; Harleaux D; Karp DD
• Characteristics of patients who refuse do-not-resuscitate orders upon admission to an acute palliative care unit in a comprehensive cancer center.
  Cancer Volume: 116 Page(s): 3061 - 3070
  06/15/2010 Authors: Parsons HA; de la Cruz MJ; Zhukovsky DS; Hui D; Delgado-Guay MO; Akitoye AE; El Osta B; Palmer L; Palla SL; Bruera E
• Methadone initiation and rotation in the outpatient setting for patients with cancer pain.
  Cancer Volume: 116 Page(s): 520 - 528
  01/15/2010 Authors: Parsons HA; de la Cruz M; El Osta B; Li Z; Calderon B; Palmer JL; Bruera E
• The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.
  J Palliat Med Volume: 13 Page(s): 33 - 38
  01/01/2010 Authors: Reddy S; Hui D; El Osta B; de la Cruz M; Walker P; Palmer JL; Bruera E
• The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.
  Cancer Epidemiol Biomarkers Prev Volume: 17 Page(s): 3262 - 3267
  11/01/2008 Authors: Reyes-Gibby CC; El Osta B; Spitz MR; Parsons H; Kurzrock R; Wu X; Shete S; Bruera E
• Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use.
  J Palliat Med Volume: 11 Page(s): 964 - 968
  09/01/2008 Authors: Parsons HA; Delgado-Guay MO; El Osta B; Chacko R; Poulter V; Palmer JL; Bruera E
• Opioids masquerading as delirium in a patient with cancer pain and obstructive sleep apnea.
  J Palliat Med Volume: 11 Page(s): 1043 - 1045
  09/01/2008 Authors: Reddy SK; Nguyen N; El Osta B; Bruera E
• Outpatient initiation and rotation to methadone in palliative care patients with cancer-related pain
  Volume: 26
  05/20/2008 Authors: El Osta BE; Parsons HA; Calderon BB; Paraskevopoulos T; Roberts LE; Navarrete L; Ramirez E; Li Z; Palmer JL; Bruera E
• Alcoholism screening in advanced cancer patients: Impact on symptom burden and opioid use
  Volume: 26
  05/20/2008 Authors: Parsons HA; Delgado-Guay MO; El Osta BE; Chacko R; Poulter V; Li Z; Palmer JL; Bruera E
• The influence of polymorphisms in cytokine genes on pain and response to analgesia in lung cancer patients receiving palliative treatment
  Volume: 26
  05/20/2008 Authors: Reyes-Gibby CC; El Osta BE; Spitz M; Parsons HA; Kurzrock R; Shete S; Bruera E
• Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors.
  J Palliat Med Volume: 11 Page(s): 422 - 427
  04/01/2008 Authors: Fadul NA; El Osta B; Dalal S; Poulter VA; Bruera E
• Cytokine genes on response to analgesia in lung cancer patients referred for palliative treatment: TNF--308 G/A, IL-6-174 G/C, and IL-8-251T/A
  Volume: 17 Page(s): 462 - 462
  02/01/2008 Authors: Reves-Gibbv CC; El Osta B; Spitz M; Parsons H; Kurzrock R; Shete S; Bruera E
• Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
  J Clin Oncol Volume: 25 Page(s): 3475 - 3481
  08/10/2007 Authors: Bruera E; El Osta B; Valero V; Driver LC; Pei B-L; Shen L; Poulter VA; Palmer JL
• Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center.
  J Palliat Med Volume: 10 Page(s): 948 - 955
  08/01/2007 Authors: Braiteh F; El Osta B; Palmer JL; Reddy SK; Bruera E
• The effect of methadone on the QTc interval in advanced cancer patients
  Volume: 25
  06/20/2007 Authors: Reddy S; Dalal S; Swafford J; El Osta B; Pei B; Palmer J; Bruera E
• Donepezil for cancer-related fatigue: A double-blind, randomized, placebo-controlled study
  Volume: 25
  06/20/2007 Authors: Bruera E; El Osta B; Valero V; Driver L; Palmer J; Pei B; Shen L; Poulter V
• Interval between first palliative care consultation and death in patients with advanced cancer
  Volume: 25
  06/20/2007 Authors: El Osta B; Palmer J; Paraskevopoulos T; Pei B; Roberts L; Poulter V; Chacko R; Bruera E
• Intractable pain: intoxication or undermedication?
  J Palliat Med Volume: 10 Page(s): 811 - 814
  06/01/2007 Authors: El Osta B; Elsayem A; Yennurajalingam S; Bruera E
• Patients' characteristics and outcomes of palliative care inpatient consults at a comprehensive cancer center.
  Volume: 24 Page(s): 474S - 474S
  06/20/2006 Authors: El Osta B; Braiteh FS; Reddy S; El Osta H; Bruera E
• Models of palliative care delivery
  Textbook of Palliative Medicine Page(s): 266 - 276
  01/01/2006 Authors: El Osta B; Bruera E